About Us
Innovate and forge ahead with leading original products in the industry
-
November 2022Approved to set up a postdoctoral scientific research workstation
-
August 20223D FloTrix® Cell CDMO platform was officially unveiled, and the expansion of the Beijing headquarters was completed
-
August 2022Topped the list of medical enterprises with 10 times growth potential of 36 krypton
-
June 2022Listed in KPMG China's first Biotechnology Innovation 50 Enterprise List
-
April 2022Tsinghua University & Huakan Biology's original research technology won the Geneva Invention Gold Medal
-
March of the same year3D FloTrix® Microcarriers for Vaccines Launched
-
March 2022Completed nearly 300 million yuan in round B financing, accelerating the industrialization of 3D cell "smart manufacturing"
-
February 2022Tianjin GMP production platform expanded to 4000 square meters, new 1200L microcarrier production line
-
July 2021The cumulative annual sales exceeded 10 million yuan, and the financing of nearly 100 million yuan was completed
-
June 2021The GMP manufacturing platform was successfully certified by the ISO9001 and IS013485 quality management systems
-
April 20213D TableTrix® Cell Microcarrier Tablet obtained the qualifications DMF for pharmaceutical excipients from the US FDA (DMF:35481)
-
February 20213D TableTrix® Cell Microcarrier Tablet obtained two qualifications for pharmaceutical excipients from CDE (Filing No.:F20200000496/F20210000003)
-
December 20203D TableTrix® microcarrier core products were released in United States, the European Union, Japan and other countries
-
October 20203D FIoTrix@ VS series of pilot-scale production-grade bioreactors were officially released in the market
-
June 2020Proprietary products of 3D TableTrix® series of microcarrier tablet officially were officially released in the market
-
January 2020The certification of intellectual property management system was completed
-
December 2019The application for "Zhongguancun Subversive Project" was successful; the certification of "National High-tech Enterprise" was obtained and the company ranked among top 3 in "Global Entrepreneurship World Cup" at the same time
-
October 2019followed by A GMP-certified manufacturing base of 2000 square meters launched in the next month.
-
March 2019In March 2019, Cytoniche received angel fund and a R&D center of 1500 square meters was therefore launched.
-
2018In 2018, the technology was successfully translated into Beijing CytoNiche Biotechnology Co., Ltd., joined by Tsinghua University equity-wise.
-
Phone
- Service hotline+86 15984333494
-
E-mail
- E-mailgulx@cytoniche.com
- TOP
京公网安备 11010802037749号